Document Type: Research Articles
Department of Pharmaceutics, Faculty of Pharmacy, Universitas Gadjah Mada, Indonesia.
Graduate student in Pharmacy Management, Faculty of Pharmacy, Universitas Gadjah Mada, Indonesia.
South East Asia is one of the world’s largest tobacco epidemic regions which tobacco smoking is known increase
the risk of various diseases, including cancer. As data from GLOBOCAN 2018 has had released on September 2018,
the aim of this study are to calculate the estimated burden of several types of cancer attributable to tobacco smoking in
Association of Southeast Asian Nations (ASEAN) 2018 and compare it with established result data in 2012. So it can be
highlight what has been achieved and what it needs to be addressed by member countries of ASEAN to strengthen cancer
prevention against tobacco smoking. This study was using descriptive epidemiological incidence and prevalence-based
research design to estimate the burden of 14 types of cancer attributable to tobacco smoking in member countries of
ASEAN, in term of incidence and mortality. The cancer incidence and mortality data gained from GLOBOCAN 2018.
According to the estimation, tobacco smoking was responsible for 121,849 new cancer cases in 2018 (106,858 male
and 14,991 female cases) in ASEAN 2018. Our findings are mostly lower than previous study in 2012, both for cancer
incidence and mortality in male and female. It seems more ASEAN member states are adopting effective policies in
the MPOWER suite of interventions such as raising taxes on tobacco, establishing smoke-free areas and implementing
graphic health warnings in decreasing number of tobacco smoking. Therefore, ASEAN member countries are strongly
encouraged to strengthen the existing tobacco control measure in order to effectively gain a significant decline of
tobacco smoking related cancer in the future.